Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Scand Cardiovasc J ; 50(5-6): 317-322, 2016.
Article in English | MEDLINE | ID: mdl-27323914

ABSTRACT

OBJECTIVES: We aim to compare patient characteristics and coronary risk factors among participants and non-participants in a survey of CHD patients. METHODS: A cross-sectional study explored characteristics and risk factors in patients hospitalized for acute myocardial infarction and/or revascularization. Study data collected from hospital medical records were compared between participants (n = 1127, 83%) and non-participants (n = 229, 16%), who did not consent to participation in the clinical study. RESULTS: Non-participants showed statistically higher prevalence of women (28% versus 21%), ethnic minorities (6% versus 3%), patients living alone (26% versus 19%), depression (19% versus 6%), anxiety (9% versus 3%), hypertension (54% versus 43%) and diabetes (24% versus 17%). Significantly higher multi-adjusted odds ratios were found for Charlson comorbidity index 3.4 (95% confidence interval (CI), 2.8, 4.3) and depression 14.5 (4.4, 121.5) in non-participants. CONCLUSIONS: Non-participants do have higher prevalence of important coronary risk factors compared to participants, and risk factor control may thus be overestimated in available prevention studies. Patients with somatic comorbidity and depression appear to be at particular risk of non-participation in the present study. New strategies accounting for the causes of nonadherence are important to improve secondary prevention in CHD.


Subject(s)
Hospitalization , Myocardial Infarction/epidemiology , Myocardial Infarction/therapy , Myocardial Revascularization , Patient Selection , Research Subjects , Adolescent , Adult , Aged , Aged, 80 and over , Anxiety/epidemiology , Anxiety/psychology , Chi-Square Distribution , Comorbidity , Cross-Sectional Studies , Depression/epidemiology , Depression/psychology , Female , Humans , Informed Consent , Logistic Models , Male , Medical Records , Middle Aged , Multivariate Analysis , Myocardial Infarction/diagnosis , Myocardial Infarction/psychology , Norway/epidemiology , Odds Ratio , Prevalence , Research Subjects/psychology , Retrospective Studies , Risk Factors , Sex Factors , Single Person , Young Adult
3.
Eur J Heart Fail ; 9(3): 234-42, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17079189

ABSTRACT

BACKGROUND: To describe the clinical characteristics of patients with stable angina pectoris who develop heart failure and the events preceding its onset. METHODS AND RESULTS: Of 7665 patients with stable angina in the ACTION trial, which compared long-acting nifedipine to placebo, 207 (2.7%) developed heart failure (HF) during a mean follow-up of 4.9 years. Those who developed HF were significantly (P<0.05) older, more often had diabetes, had a more extensive history of cardiovascular disease, lower ejection fractions, a higher serum creatinine and glucose, a lower haemoglobin, and were more often on blood pressure lowering drugs. A cardiac event or an intervention (n=155), a significant non-cardiac infection (n=19) or poor control of hypertension (n=12) preceded the development of HF in 186/207 cases (90%). There was no obvious precipitating factor in the remaining 21 patients (10%). Myocardial infarction increased the risk of the development of new HF within one week more than 100-fold. Nifedipine reduced the incidence of HF by 29% (P=0.015). CONCLUSIONS: The development of heart failure is uncommon in patients with stable angina, and even less so in the absence of an obvious precipitating factor.


Subject(s)
Angina Pectoris/complications , Heart Failure/etiology , Aged , Angina Pectoris/drug therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Myocardial Infarction/complications , Myocardial Infarction/physiopathology , Nifedipine/therapeutic use , Precipitating Factors , Proportional Hazards Models , Prospective Studies , Time Factors , Treatment Outcome , Vasodilator Agents/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...